NEW YORK (Reuters Health) – Methadone is a safe, effective first- or second-line treatment of cancer pain, even in outpatients, a retrospective study suggests. Concerns over its long…
NEW YORK (Reuters Health) – For men with hot flushes from androgen suppression for prostate cancer, medroxyprogesterone appears to be the best option for relief, according to a…
NEW YORK (Reuters Health) – New research suggests that high-dose vitamin D can be safely given to breast cancer patients with bone metastases, but it will not affect…
NEW YORK (Reuters Health) – Recombinant human erythropoietin (EPO) provides no benefit after acute ischemic stroke, and may even be dangerous, particularly in patients receiving systemic thrombolysis. These…
NEW YORK (Reuters Health) – New research shows that antidiabetes agents are not equal when it comes to cardiovascular risks and mortality. According to a report in the…
NEW YORK (Reuters Health) – Elevated C-reactive protein (CRP) levels are linked with an increased risk of stent thrombosis and cardiovascular events in patients with drug-eluting stents, say…
NEW YORK (Reuters Health) – Ultrasound is a reliable means of screening for tethered cord syndrome in infants with dorsal midline skin stigmata, new research shows. However, such…
NEW YORK (Reuters Health) – The risk of venous thromboembolism (VTE) after surgery is probably higher and longer-lasting than previously thought, data from the UK’s Million Women Study…
Robert Goldberg, MD, Chief, Orbital and Opthalmic Plastic Surgery, David Geffen School of Medicine UCLA, discusses new advances on the medical and surgical sides of Graves’ Eye Disease,…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses diabesity, obesity with diabetes, and reminds doctors why we need to screen patients first for…
